Navigation Links
Kensey Nash Reports Second Quarter Fiscal Year 2011 Financial Results
Date:2/1/2011

e the Company's actual results to differ materially from those in the forward-looking statements including, without limitation, St. Jude Medical's success in selling the Angio-Seal device and the extent to which, after December 31, 2010, St. Jude is able to and does in fact rely on its internal manufacturing to fulfill its requirements for collagen plugs for the Angio-Seal device, the success of the Company's customers and partners (including St. Jude Medical, Arthrex, Orthovita, Orteq and Synthes) in selling Kensey Nash related products in the marketplace, the Company's success in its research and development efforts (including in its cartilage repair, extracellular matrix and endovascular programs), the success of clinical trials in both the U.S. and outside the U.S. to support regulatory approval of the Company's products, and competition from other technologies, as well as tax and other risks associated with healthcare reform, economic conditions and foreign currency fluctuations. For a detailed discussion of factors that could affect the Company's future operating results, please see the Company's SEC filings, including the disclosures under "Risk Factors" in those filings.  Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason.

– FINANCIAL INFORMATION TO FOLLOW –KENSEY NASH CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)Three MonthsSix MonthsEnded December 31, 2010Ended December 31, 20102010200920102009Revenues:Net salesBiomaterial sales

$
,630,328$   11,634,701$ 21,051,784$ 24,209,747Endovascular sales

269,333834,990727,8321,692,646Total net sales

10,899,66112,469,69121,779,61625,902,393Royalty income

6,455,2626,600,94112,539,90612,910,057Total revenues

17,354,92319,070,632
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
2. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
3. Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
4. Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
5. Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
6. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
7. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
8. Par Pharmaceutical Reports Second Quarter 2008 Results
9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
10. Pharmos Corporation Reports 2008 Second Quarter Results
11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... --  Sequenom, Inc. (NASDAQ: SQNM ), ... solutions, and Mayo Medical Laboratories (MML), the ... the United States , have announced a license ... "We have great appreciation for Mayo Clinic,s commitment ... the opportunity to partner with the organization,s leading clinical ...
(Date:7/29/2014)... 2014) Tough, ultralight foam of atom-thick sheets can ... chemical process invented at Rice University. , In ... nanoscale building, with floors and walls that reinforce each ... materials: floors and walls of graphene oxide that self-assemble ... , The researchers say the foam could find use ...
(Date:7/29/2014)... NEW YORK , July 29, 2014  Pomerantz ... Impax Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL).  ... Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. ... certain of its officers and/or directors have violated Sections ... 1934.  On July 29, 2014, Impax ...
(Date:7/29/2014)... Pa. , July 29, 2014  Discovery ... dedicated to advancing a new standard of respiratory ... results on August 5, 2014 before the open ... The Company will host a live teleconference and ... During the conference call, Discovery Labs, management will ...
Breaking Biology Technology:Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4Tough foam from tiny sheets 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2
... Christenson will assume duties as director of the state ... Secretary Cory Nettles announced the hire last ... initiative. , ,Part of the key to our ... in collaborative efforts. We hope to connect the tech ...
... For Ron Reynolds, an early peek at what would turn ... Way came through a hole in the ceiling. , ,As ... late 1970s, Reynolds sawed a hole in the ceiling of ... a specially built spectrometer through the roof of the building, ...
... of molten steel as the representative symbol of a ... the cubicle farm. Instead of coke and iron ore, ... data and information into knowledge and ideas: An invisible ... output is knowledge. Every physical product has a knowledge ...
Cached Biology Technology:Nettles Names Christenson as Director of Bureau of Entrepreneurship 2Journey Leads Astronomer to New Galactic Structure 2Journey Leads Astronomer to New Galactic Structure 3Transforming Information to Knowledge 2
(Date:7/29/2014)... Northern Territories in Canada and have sent smoke drifting ... on. NASA,s Aqua satellite collected this natural-color image ... July 26, 2014. Actively burning areas, detected by MODIS,s ... smoke are drifting northward in this image. Smoke ... Fire has caused power outages in the area and ...
(Date:7/29/2014)... Kent has shown for the first time how the ... could have a major impact on cancer therapy development. ... the mechanism whereby the physical properties of the internal ... are ,fine-tuned, to undertake different functions. , While some ... a framework for the cell, others are more dynamic, ...
(Date:7/29/2014)... ground breaking new book that brings together two of ... raise the profile of insect fossils through stunning photographs ... Penney and James E Jepson, details the incredible preservation ... setting the scene for what these remarkable fossils can ... even the future of our planet. Like the mosquito ...
Breaking Biology News(10 mins):Unique images bring fossil insects back to life 2
... engineered yeast strain can simultaneously consume two types of ... sugars are glucose, a six-carbon sugar that is relatively ... has been much more difficult to utilize in ethanol ... adding to earlier advances, reduces or eliminates several major ...
... 24, 2010) - Three weeks of oral resveratrol or ... microRNA activity close to their pre-event levels in excised ... were attributed to exerting the majority of the gene-switching ... microRNA optimally regulated by Longevinex and two optimally by ...
... New findings from the Monell Center reveal that weight ... formula the infant is consuming. The findings have implications related ... and other diseases later in life. "Events early in ... most significant influences is early growth rate," said study lead ...
Cached Biology News:Team overcomes major obstacles to cellulosic biofuel production 2Team overcomes major obstacles to cellulosic biofuel production 3Team overcomes major obstacles to cellulosic biofuel production 4Longevinex exerts greater influence over genes than resveratrol 2Longevinex exerts greater influence over genes than resveratrol 3Not all infant formulas are alike: Differential effects on weight gain 2
Mouse monoclonal [4i144] to HLA Class II DQ1 7 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 2 Antigen DQ1,7....
ASCIZ...
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID: ...
...
Biology Products: